INSUBCONTINENT EXCLUSIVE:
Newly-appointed board of Fortis Healthcare, which is in the process of finding an investor, has again deferred approval of quarterly and
annual financial results for the period ended March 31, 2018, saying the issue requires more deliberation.
The board, which met on June 25
for considering results, will reconvene today.
"This is to inform that the Board of Directors of the company held a meeting on June 25,
2018, for considering the standalone and consolidated annual accounts for 2017-18 along with the financial results for the quarter and
period ended March 31, 2018.
"The members of the board deliberated upon the same and had a detailed discussion with the management, legal
advisors and the statutory auditors," Fortis said in a regulatory filing.
It further said in view of the ongoing discussions on the annual
accounts, which requires further deliberation, the board decided to adjourn the meeting to be reconvened today.
Fortis said the board
meeting commenced at 1600 hours on June 25 and was adjourned at 0215 hours on June 26.
On June 11, Fortis board deferred approval of
quarterly and annual financial results to June 25 saying more time was needed to consider the aspects of outcome of an internal
investigation on alleged financial irregularities.
On May 30 as well, the board had deferred approval of the results to June 11 citing
ongoing deliberations of the conclusions arising from the internal investigation.
The healthcare chain, which is in the process of finding a
buyer, had appointed a law firm in March to investigate allegations of fund diversion from Fortis by former promoters Singh
brothers.
Markets regulator Sebi is also investigating the matter related to alleged lapses at Fortis and Religare Enterprises
Apart from Sebi, the Serious Fraud Investigation Office (SFIO) has also initiated a probe into the alleged financial irregularities at the
two companies.
The probes were initiated against the backdrop of reports that Fortis promoters Malvinder Singh and Shivinder Singh took at
least USD 78 million out of the company without any board approval about a year ago.
